70,000,000 preferred shares converted into 1,166,667 preferred shares to comport with previous 60:1 r/s. https://www.promisneurosciences.com/investors/sec-filings/content/0001558370-23-019700/0001558370-23-019700.pdf The Exchange was effected on a 60:1 basis to reflect a previously effected consolidation of the Company’s Common Shares as of June 28, 2022, which had not included the Series 1
...more